[{"id":"c890ba84-1c6e-4f54-893d-6a2733043de5","acronym":"","url":"https://clinicaltrials.gov/study/NCT04925804","created_at":"2022-02-20T15:52:36.061Z","updated_at":"2025-02-25T14:59:56.138Z","phase":"","brief_title":"Unraveling Genetics of HypoPhosPhatasia (HPP Genetics)","source_id_and_acronym":"NCT04925804","lead_sponsor":"CENTOGENE GmbH Rostock","biomarkers":" ALPL","pipe":"","alterations":" ","tags":["ALPL"],"overall_status":"Completed","enrollment":" Enrollment 16","initiation":"Initiation: 06/02/2021","start_date":" 06/02/2021","primary_txt":" Primary completion: 12/02/2021","primary_completion_date":" 12/02/2021","study_txt":" Completion: 12/02/2021","study_completion_date":" 12/02/2021","last_update_posted":"2021-12-29"},{"id":"e8a0af9e-afc6-4742-823e-11da45748c35","acronym":"","url":"https://clinicaltrials.gov/study/NCT02204943","created_at":"2021-01-18T10:19:19.555Z","updated_at":"2025-02-25T17:22:25.811Z","phase":"Phase 1","brief_title":"Pharmacodynamic Study of Radium-223 in Men With Bone Metastatic Castration-Resistant Prostate Cancer","source_id_and_acronym":"NCT02204943","lead_sponsor":"Duke University","biomarkers":" ALPL","pipe":"","alterations":" ","tags":["ALPL"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Xofigo (radium Ra-223 dichloride)"],"overall_status":"Completed","enrollment":" Enrollment 20","initiation":"Initiation: 05/06/2015","start_date":" 05/06/2015","primary_txt":" Primary completion: 07/31/2017","primary_completion_date":" 07/31/2017","study_txt":" Completion: 07/31/2017","study_completion_date":" 07/31/2017","last_update_posted":"2018-06-08"}]